Assignee
SACKSTEIN ROBERT
12 granted patents·13 pending applications·59 citations·filing 2001–2025
Top patents by PatentIndex Score
25 records- 0193US8084236B2Compositions and methods for modifying cell surface glycansSACKSTEIN ROBERT·Filed 2007·Granted Dec 27, 2011·18 cites·51 claims
- 0288US7998740B2Cytokine induction of selectin ligands on cellsSACKSTEIN ROBERT·Filed 2007·Granted Aug 16, 2011·9 cites·13 claims
- 0388US7816500B2Antibody SACK-1 that binds CD44 glycoformsSACKSTEIN ROBERT·Filed 2009·Granted Oct 19, 2010·7 cites·2 claims
- 0487US8728810B2Methods for modifying cell surface glycansSACKSTEIN ROBERT·Filed 2011·Granted May 20, 2014·7 cites·27 claims
- 0581US8852935B2Compositions and methods for modifying cell surface glycansSACKSTEIN ROBERT·Filed 2011·Granted Oct 7, 2014·3 cites·19 claims
- 0681US7875585B2Hematopoietic cell E-selectin / L-selectin ligand glycosylated CD44 polypeptideSACKSTEIN ROBERT·Filed 2001·Granted Jan 25, 2011·11 cites·11 claims
- 0779US9523078B2Method for increasing the E-selectin binding affinity of a population of cells expressing a CD44 polypeptideSACKSTEIN ROBERT·Filed 2012·Granted Dec 20, 2016·3 cites·16 claims
- 0874US11535831B2Compositions and methods for modifying cell surface glycansSACKSTEIN ROBERT·Filed 2020·Granted Dec 27, 2022·0 cites·20 claims
- 0972US10370642B2Hematopoietic progenitor cell populations having affinity for E-selectin / L-selectinSACKSTEIN ROBERT·Filed 2015·Granted Aug 6, 2019·1 cites·9 claims
- 1071US2026007746A1Compositions and methods for treatment of inflammatory disordersSACKSTEIN ROBERT·Filed 2025·Application pending·0 cites
- 1170US2023310602A1Compositions and methods for treatment of inflammatory disordersSACKSTEIN ROBERT·Filed 2022·Application pending·0 cites
- 1267US9914913B2Compositions and methods for modifying cell surface glycansSACKSTEIN ROBERT·Filed 2014·Granted Mar 13, 2018·0 cites·8 claims
- 1364US2018127731A1Compositions and methods for modifying cell surface glycansSACKSTEIN ROBERT·Filed 2018·Application pending·0 cites
- 1461US2014199316A1Methods of treating complications and disorders associated with g-csf administrationSACKSTEIN ROBERT·Filed 2014·Application pending·0 cites
- 1558US8765126B2Methods of treating complications and disorders associated with G-CSF administrationSACKSTEIN ROBERT·Filed 2012·Granted Jul 1, 2014·0 cites·14 claims
- 1656US8633026B2Cytokine induction of selectin ligands on cellsSACKSTEIN ROBERT·Filed 2011·Granted Jan 21, 2014·0 cites·20 claims
- 1756US2013058959A1Hematopoietic cell selectin ligand polypeptides and methods of use thereofSACKSTEIN ROBERT·Filed 2012·Application pending·0 cites
- 1856US2014170120A1Cytokine induction of selectin ligands on cellsSACKSTEIN ROBERT·Filed 2014·Application pending·0 cites
- 1954US2006210558A1Hematopoietic cell selectin ligand polypeptides and methods of use thereofSACKSTEIN ROBERT·Filed 2005·Application pending·0 cites
- 2053US2011189139A1Hematopoietic Cell E-Selectin/L-Selectin Ligand Glycosylated CD44 PolypeptideSACKSTEIN ROBERT·Filed 2011·Application pending·0 cites
- 2153US2016194376A1Hematopoietic cell selectin ligand polypeptides and methods of use thereofSACKSTEIN ROBERT·Filed 2015·Application pending·0 cites
- 2247US2005214283A1Antibodies to CD44 glycoforms and uses thereofSACKSTEIN ROBERT·Filed 2004·Application pending·0 cites
- 2345US2019201444A1Glycoengineering of e-selectin ligandsSACKSTEIN ROBERT·Filed 2017·Application pending·0 cites
- 2443US2013059333A1Hematopoietic cell selectin ligand polypeptides and methods of use thereofSACKSTEIN ROBERT·Filed 2012·Application pending·0 cites
- 2541US2006003924A1Sulfation-independent L-selectin or E-selectin ligand (HCELL) and therapeutics thereofSACKSTEIN ROBERT·Filed 2005·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →